Moderna
FDA Approves Spikevax COVID Shot in Children at Increased Risk
The FDA approved Moderna’s COVID-19 vaccine, Spikevax, in children between the ages of 6 months and 11 years ...
JULY 15, 2025
HHS Pulls Funding for Moderna Bird Flu Vaccine Development
HHS has pulled funding for Moderna to continue development of its investigational avian influenza vaccine and ...
JUNE 5, 2025
FDA Approves New Moderna COVID-19 Shot
The FDA has approved a new COVID-19 vaccine from Moderna, mNEXSPIKE (mRNA-1283).
JUNE 4, 2025
Positive Phase 3 Results for Moderna’s Combined COVID-Flu Vaccine
Moderna’s investigational combination influenza and COVID-19 vaccine has met its phase 3 trial primary end ...
APRIL 11, 2025
Updated mRNA COVID-19 Vaccines Against Omicron Variants Approved
The 2023-2024 COVID-19 vaccines were formulated to more closely target currently circulating variants and to ...
SEPTEMBER 11, 2023
Positive Results From 2 Leading RSV Vaccine Trials
Moderna has announced the investigational mRNA vaccine (mRNA-1345) targeting RSV in older adults, has met the ...
JANUARY 20, 2023
FDA: Children 6 Months+ Now Eligible for Updated, Bivalent COVID-19 Vaccines
Children 6 months of age and older are now eligible to receive the updated, bivalent COVID-19 vaccines (Moderna and ...
DECEMBER 12, 2022
FDA Authorizes Moderna’s and Pfizer’s Bivalent COVID-19 Vaccines for Boosters in Children Ages 5+
The FDA amended the emergency use authorizations of both the Moderna and Pfizer-BioNTech bivalent COVID-19 vaccines ...
OCTOBER 12, 2022
FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Booster Doses
The FDA amended the EUAs of the Moderna and the Pfizer-BioNTech COVID-19 vaccines to authorize bivalent ...
AUGUST 31, 2022
New Moderna COVID-19 Booster Candidate Targets Omicron
Moderna says its mRNA vaccine booster candidate was effective against the omicron variant of SARS-CoV-2, the ...
JUNE 9, 2022
Moderna Begins Phase 3 Trial for RSV Vaccine
The experimental mRNA-1345 RSV vaccine is based on the same messenger RNA technology used in the Moderna's COVID-19 ...
MARCH 9, 2022
ACIP Votes to Recommend Use of Spikevax in Adults 18 and Older
The ACIP recommended the use of Spikevax, which became fully licensed in January, for those 18 and older. The rest ...
FEBRUARY 4, 2022
